Metabolic complications of antiretroviral therapies.
Dube
M P
MP
University of Southern California, School of Medicine, Los Angeles, CA.                 ¿¿                        98703893
Sattler
F R
FR
D000273:Adipose Tissue / Q000378:metabolism / Q000473:pathology*; D001823:Body Composition; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000378:metabolism; D004198:Disease Susceptibility; D004359:Drug Therapy, Combination; D005947:Glucose / Q000378:metabolism; D015658:HIV Infections / Q000188:drug therapy* / Q000378:metabolism; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000378:metabolism; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced* / Q000378:metabolism
D017320:HIV Protease Inhibitors; D005947:Glucose